Press release
Important Players Present In The Hematopoietic Stem Cell Transplantation Market
Rising incidence of leukemia and lymphoma and continuous research on hematopoietic stem cells are expected to drive market growth
As per 2017 report by Leukemia and Lymphoma Society, the U.S. alone is expected to account for a prevalence of 8,16,834 and incidence of 80,500 for lymphoma. Increasing rate of incidence is in turn, expected to increase the demand for hematopoietic stem cell transplantation thus, propelling growth of the hematopoietic stem cell transplantation (HSCT) market. Increasing awareness about stem cell therapies among the population is also expected to propel growth of the hematopoietic stem cell transplantation market. As per survey by World Network for Blood and Marrow Transplantation (WBMN), around one million hematopoietic stem cell transplantation procedures were performed during 2006 to 2014, which indicates potential opportunities for market players.
However, high costs associated with hematopoietic stem cell transplantation procedures are expected to hinder growth of the market. Other factors such as difficulty in finding a donor for allogeneic transplantation, technological barriers (currently used culture technologies, point of care delivery, and lack of analytical assay), and side effects such as graft vs. host disease, are also expected to slow down growth of the hematopoietic stem cell transplantation market.
Ask For Table Of Content@
https://www.coherentmarketinsights.com/ongoing-insight/toc/1250
Global Hematopoietic Stem Cell Transplantation Market Taxonomy
On the basis of indication:
Leukemia,Lymphatic disorder,Myeloma,Other non-malignant disorders (thalassemia, sickle cell anemia, Osteoporosis, Immunodeficiency syndrome)
On the basis of application:
Peripheral blood cells,Bone marrow,Umbilical cord blood
Increasing adoption of the growing trend of personalized medicine is expected to drive growth of the hematopoietic stem cells transplantation market. A collaborative research study on hematopoietic stem cell transplantation initiated by World Network for Blood and Marrow Transplantation (WBMN) in 2013 in the domain of promotion of access to hematopoietic stem cell transplantation, developed a donation guidance document, technical and scientific input on safety, and quality of HSCT as mentioned in annual report of the WBMN.
In March 2017, Gilead Sciences announced the acquisition of Kite Pharma, which produces products such as Axi-cel to treat non-Hodgkin lymphoma. Plasticell, which specializes in the development of stem cell technologies and cell-based therapies, announced entering into an agreement with Nan yang Technological University (NTU) in Singapore on March 2017, to advance its therapeutic stem cell pipeline. Plasticell also announced collaboration with Anthony Nolan, a research organization in blood cancer, to progress clinical development of Plasticell’s ex vivo expanded cord blood-derived hematopoietic stem cell product in December 2017. Also, GE Healthcare announced the introduction of Thaw CB1000, for thawing large volumes of cell therapies cryopreserved in cryo-bags majorly intended for use in research laboratory, in September 2017.
Important players present in the hematopoietic stem cell transplantation market
Major players operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., CellGenix Technologie Transfer GmbH, Kite Pharma Inc., Regen Biopharma Inc., BiolineRx, Cynata Therapeutics, Lonza Group Ltd, Cesca Therapeutics Inc, TiGenix N.V., Escape Therapeutics Inc., Bluebird Bio, and Cellular Dynamics International.
Get More Details On this Report:
https://www.coherentmarketinsights.com/ongoing-insight/hematopoietic-stem-cell-transplantation-market-1250
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Important Players Present In The Hematopoietic Stem Cell Transplantation Market here
News-ID: 931499 • Views: …
More Releases from Biotechnology by CMI
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management
Multiple sclerosis (MS) is a disabling autoimmune disease affecting the brain and the spinal cord, eventually causing nerve deterioration or permanent damage. The types of MS include relapsing-remitting MS (RRMS), primary progressive MS (PPMS) and secondary progressive MS (SPMS). RPMS is the most common type characterized by defined attacks with increasing neurological symptoms, PPMS is the rare form characterized by gradual progression…
Ebola Vaccine Market - Global Industry Insights, 2017-2025
Increasing number of Ebola cases in affected regions and new vaccine development for this are expected to be factors driving growth of the market
Increasing mortality rates due to Ebola is expected to be a major factor for growth of the market. According to World Health Organization, in January 2018, around 50% people infected with EVD, have died. African countries such as Siberia, Sierra Leone, Guinea, Democratic Republic of Congo, Senegal,…
Oncology Biosimilars Market-Opportunity Analysis, 2017-2025
Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or approved products. Several biologics for oncology have already lost their patents, and some are in its period of expiry. As more products are expected to lose patents, biosimilar is expected to gain popularity. Leading generic players such as Mylan N.V., Teva Pharmaceutical Industries…
Kidney Transplant Holds The Maximum Share Of Organ Transplant Market Due To Risi …
Organ transplantation is the surgical operation in which a healthy organ is removed from one person and transplanted to another person whose organ is failed or damaged. In the organ transplantation, the donated organ may be from living donor, deceased donor, or from an animal. Whereas in some cases an artificial organ is used in the transplantation procedure. Organ transplantation gives new life to the individual with damaged or failed…
More Releases for Hematopoietic
Hematopoietic Agents Market Size, Industry Outlook and Forecast to 2028
The report “Global Hematopoietic Agents Market Growth 2021-2028” from Databridge Market Research includes data and information about market structure and size. The purpose of this research is to give market knowledge and strategic insights to assist in decision making, making informed investment decisions, and identifying potential growth opportunities.
Download Free Sample Report: To Know The Impact Of COVID-19 On This Industry @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hematopoietic-agents-market
The Global Hematopoietic Agents Market market report also indicates…
Hematopoietic Agents Market Estimated to Flourish by 2024
Hematopoiesis is a process of continuous replacement of most mature blood cells. New produced blood cells must be adequate to meet the basic demand of body. Hematopoiesis process needs an ample supply of minerals (e.g., iron, copper, and cobalt) and vitamins (e.g., vitamin B12, folic acid, ascorbic acid, pyridoxine, and riboflavin). Normal hematopoiesis process produces more than 400 billion blood cells each day, this production can be increased several-fold with…
Global Hematopoietic Stem Cell Transplantation (HSCT) Market Research Report
This report studies the global Hematopoietic Stem Cell Transplantation (HSCT) market status and forecast, categorizes the global Hematopoietic Stem Cell Transplantation (HSCT) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Escape Therapeutics Inc. Cryo-Save AG Regen Biopharma Inc. CBR Systems Inc.…
Hematopoietic Stem Cell Transplantation (HSCT) Market-Opportunity Analysis, 2017 …
Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow or umbilical cord blood are transplanted into a patient. Hematopoietic stem cell transplantation is commonly used in the treatment of lymphoma (Hodgkin, Non-Hodgkin), leukemia, multiple myeloma, thalassemia, sickle cell anemia, and osteoporosis. It includes two transplantation sources namely, autologous that uses stem cells from the patient’s own body and allogeneic…
Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Report 2018
In this report, the Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with…
Hematopoietic Stem Cell Transplantation Market US$37.61 bn by 2025
The competitive landscape in the global market for hematopoietic stem cell transplantation (HSCT) is characterized by the rivalry between the leading market players, such as Regen Biopharma Inc., Cryo-Save AG, Pluristem Therapeutics Inc., and CBR Systems Inc., finds a new research study by Transparency Market Research (TMR).
These players are focusing aggressively over innovation and technological advancements in order to penetrate new therapeutic areas. The improvement in the global economic condition…
